Weekly injections of the GLP-1 semaglutide reduce alcohol consumption in patients with obesity seeking treatment for alcohol ...

Ozempic can help people who are battling alcoholism, a major new clinical trial has concluded. People with alcohol use ...

Scientists are learning that GLP-1s may be an effective weight-loss medication for so many people because, in part, they ...

Research indicates semaglutide can significantly decrease alcohol consumption and cravings in individuals with comorbid ...

Glucagon-like peptide-1 (GLP-1) receptor agonists may be a potential novel treatment for alcohol use disorder, according to a ...

Can semaglutide reduce alcohol consumption? New research explores its role in alcohol use disorder and obesity.

Semaglutide might offer a novel treatment pathway for alcohol use disorder in those with comorbid obesity. Learn more.

A Danish clinical trial has found that semaglutide, a drug used for obesity and diabetes, significantly reduced heavy drinking in patients with alcohol use disorder and obesity. Over 26 weeks, ...

National Institutes of Health (NIH) released the following: A team of National Institutes of Health (NIH) scientists and ...

Novo Nordisk (NYSE:NVO) is exploring semaglutide as a potential treatment for alcohol use disorder, expanding beyond its current uses in diabetes and obesity. The company has also begun Phase 1 trials ...

Once-weekly semaglutide was tied to a reduction in heavy drinking days among adults with obesity and alcohol use disorder, ...